Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.825 USD | -2.55% | -0.13% | -26.80% |
Apr. 17 | Morgan Stanley Trims Price Target on WalkMe to $11 From $12, Keeps Equalweight Rating | MT |
Apr. 15 | Barclays Adjusts Price Target on WalkMe to $8.50 From $10, Maintains Underweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.80% | 738M | |
-20.34% | 26.51B | |
-1.44% | 9.04B | |
-9.42% | 4.47B | |
+2.35% | 485M | |
-11.57% | 430M | |
-9.44% | 266M | |
-29.61% | 195M | |
-44.02% | 175M | |
-0.82% | 155M |
- Stock Market
- Equities
- WKME Stock
- News WalkMe Ltd.
- WalkMe Reports Wider Q3 Non-GAAP Loss, Higher Revenue; Sets Q4 Sales Outlook; Tweaks Full-Year Guidance